TWST: Please begin with a brief introduction to your coverage, including some of the specific names you follow.
Mr. Peaker: I'm an Analyst in Oppenheimer. I cover a wide range of biotech companies that's not necessari

Boris Peaker is an Executive Director and Senior Analyst at Oppenheimer & Co. Inc., covering the emerging biotechnology sector. Prior to joining Oppenheimer & Co., Inc., Mr. Peaker worked at Rodman & Renshaw covering small and midcap biotech companies across multiple therapeutic areas... More
Published April 26, 2014 in Biotechnology and Pharmaceuticals
Buy ($75)Published June 18, 2013 in REITs
Buy ($75)"We cover 27 stocks ranging from apartments to student housing, shopping centers, malls, office, industrial and the net lease space.
TWST: When we spoke a year ago, you were bullish about the REIT space overall"
Published June 18, 2013 in REITs
Buy ($75)Published June 18, 2013 in REITs
Buy ($75)Published June 18, 2013
Published June 7, 2013
Published June 7, 2013